Hyperfine (HYPR)
(Delayed Data from NSDQ)
$1.16 USD
+0.01 (0.87%)
Updated Aug 5, 2024 04:00 PM ET
After-Market: $1.16 0.00 (0.00%) 4:34 PM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
HYPR 1.16 +0.01(0.87%)
Will HYPR be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for HYPR based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for HYPR
Hyperfine's (HYPR) Swoop System Gets New FDA-Cleared Software
Hyperfine (HYPR) to Release ACTION PMR Study Data for Swoop
HYPR: What are Zacks experts saying now?
Zacks Private Portfolio Services
Hyperfine (HYPR) Inks New Partnerships to Expand in Europe
Why You Should Bet on 5 Top-Ranked Stocks With Rising P/E
Hyperfine, Inc. (HYPR) Reports Q1 Loss, Tops Revenue Estimates
Other News for HYPR
Hyperfine Announces Presentation of Initial Data from Observational Clinical Studies Evaluating the Use of Portable MR Brain Imaging for Alzheimer's Patients
Hyperfine Announces FDA Clearance of Software Update That Enables Faster Acquisition of Best-in-Class Ultra-Low-Field Brain Images
FDA clears Hyperfine software update for low-field brain images
Portable MRI as a Tissue Clock for Acute Ischemic Stroke: Multi-Site Study to be Published in August 2024 Edition of Annals of Neurology Shows the Value of the Ultra-Low-Field Swoop? Portable MR Imaging? System in Acute Stroke Diagnosis
Hyperfine, Inc. to Announce Second Quarter 2024 Financial Results on August 8, 2024